Survival and disease progression in human immunodeficiency virus-infected women after an index delivery

D. J. Gloeb, Shenghan Lai, J. Efantis, M. J. O'Sullivan

Research output: Contribution to journalArticle

Abstract

Objective: Our objective was to provide information on survival and disease progression in human immunodeficiency virus antibody-positive pregnant women undergoing prospective evaluation. Study design: After an index delivery, 103 human immunodeficiency virus antibody-positive pregnant women were identified and underwent follow-up for 3 years. The patients were assessed medically and/or gynecologically when hospitalized for a human immunodeficiency virus-related illness or at each follow-up visit. The life-table method was used to estimate the cumulative probabilities of survival and remaining free of acquired immunodeficiency syndrome. Cox's proportional-hazards analyses were used to identify prognostic factors for survival and progression to acquired immunodeficiency syndrome. Results: The majority of human immunodeficiency virus-infected pregnant women were alive 3 years later. Lymphadenopathy syndrome or herpes genitalis was significantly associated with a subsequent diagnosis of acquired immunodeficiency syndrome. Of the 103 original patients, six had acquired immunodeficiency syndrome at the index delivery and acquired immunodeficiency syndrome developed in 24. Approximately 94% of evaluable patients with development of acquired immunodeficiency syndrome had CD4-lymphocyte counts <200/mm3. The most common opportunistic infection was Pneumocystis carinii pneumonia. Acquired immunodeficiency syndrome and postpartum zidovudine therapy were independent prognostic factors affecting survival. Conclusion: Survival was affected by Centers for Disease Control group status of human immunodeficiency virus infection at the index delivery.

Original languageEnglish (US)
Pages (from-to)152-157
Number of pages6
JournalAmerican Journal of Obstetrics and Gynecology
Volume167
Issue number1
StatePublished - 1992
Externally publishedYes

Fingerprint

Disease Progression
Acquired Immunodeficiency Syndrome
HIV
Survival
Pregnant Women
AIDS-Related Complex
Herpes Genitalis
Pneumocystis Pneumonia
Life Tables
Zidovudine
Antibodies
Opportunistic Infections
Virus Diseases
Centers for Disease Control and Prevention (U.S.)
CD4 Lymphocyte Count
Postpartum Period
Control Groups

Keywords

  • acquired immunodeficiency syndrome (AIDS) in pregnancy, survival of human immunodeficiency virus (HIV)-infected women
  • Cox's model
  • time-dependent covariates

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Survival and disease progression in human immunodeficiency virus-infected women after an index delivery. / Gloeb, D. J.; Lai, Shenghan; Efantis, J.; O'Sullivan, M. J.

In: American Journal of Obstetrics and Gynecology, Vol. 167, No. 1, 1992, p. 152-157.

Research output: Contribution to journalArticle

@article{5cba15d7d2c94df6b7eaa6d3d03b39ae,
title = "Survival and disease progression in human immunodeficiency virus-infected women after an index delivery",
abstract = "Objective: Our objective was to provide information on survival and disease progression in human immunodeficiency virus antibody-positive pregnant women undergoing prospective evaluation. Study design: After an index delivery, 103 human immunodeficiency virus antibody-positive pregnant women were identified and underwent follow-up for 3 years. The patients were assessed medically and/or gynecologically when hospitalized for a human immunodeficiency virus-related illness or at each follow-up visit. The life-table method was used to estimate the cumulative probabilities of survival and remaining free of acquired immunodeficiency syndrome. Cox's proportional-hazards analyses were used to identify prognostic factors for survival and progression to acquired immunodeficiency syndrome. Results: The majority of human immunodeficiency virus-infected pregnant women were alive 3 years later. Lymphadenopathy syndrome or herpes genitalis was significantly associated with a subsequent diagnosis of acquired immunodeficiency syndrome. Of the 103 original patients, six had acquired immunodeficiency syndrome at the index delivery and acquired immunodeficiency syndrome developed in 24. Approximately 94{\%} of evaluable patients with development of acquired immunodeficiency syndrome had CD4-lymphocyte counts <200/mm3. The most common opportunistic infection was Pneumocystis carinii pneumonia. Acquired immunodeficiency syndrome and postpartum zidovudine therapy were independent prognostic factors affecting survival. Conclusion: Survival was affected by Centers for Disease Control group status of human immunodeficiency virus infection at the index delivery.",
keywords = "acquired immunodeficiency syndrome (AIDS) in pregnancy, survival of human immunodeficiency virus (HIV)-infected women, Cox's model, time-dependent covariates",
author = "Gloeb, {D. J.} and Shenghan Lai and J. Efantis and O'Sullivan, {M. J.}",
year = "1992",
language = "English (US)",
volume = "167",
pages = "152--157",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Survival and disease progression in human immunodeficiency virus-infected women after an index delivery

AU - Gloeb, D. J.

AU - Lai, Shenghan

AU - Efantis, J.

AU - O'Sullivan, M. J.

PY - 1992

Y1 - 1992

N2 - Objective: Our objective was to provide information on survival and disease progression in human immunodeficiency virus antibody-positive pregnant women undergoing prospective evaluation. Study design: After an index delivery, 103 human immunodeficiency virus antibody-positive pregnant women were identified and underwent follow-up for 3 years. The patients were assessed medically and/or gynecologically when hospitalized for a human immunodeficiency virus-related illness or at each follow-up visit. The life-table method was used to estimate the cumulative probabilities of survival and remaining free of acquired immunodeficiency syndrome. Cox's proportional-hazards analyses were used to identify prognostic factors for survival and progression to acquired immunodeficiency syndrome. Results: The majority of human immunodeficiency virus-infected pregnant women were alive 3 years later. Lymphadenopathy syndrome or herpes genitalis was significantly associated with a subsequent diagnosis of acquired immunodeficiency syndrome. Of the 103 original patients, six had acquired immunodeficiency syndrome at the index delivery and acquired immunodeficiency syndrome developed in 24. Approximately 94% of evaluable patients with development of acquired immunodeficiency syndrome had CD4-lymphocyte counts <200/mm3. The most common opportunistic infection was Pneumocystis carinii pneumonia. Acquired immunodeficiency syndrome and postpartum zidovudine therapy were independent prognostic factors affecting survival. Conclusion: Survival was affected by Centers for Disease Control group status of human immunodeficiency virus infection at the index delivery.

AB - Objective: Our objective was to provide information on survival and disease progression in human immunodeficiency virus antibody-positive pregnant women undergoing prospective evaluation. Study design: After an index delivery, 103 human immunodeficiency virus antibody-positive pregnant women were identified and underwent follow-up for 3 years. The patients were assessed medically and/or gynecologically when hospitalized for a human immunodeficiency virus-related illness or at each follow-up visit. The life-table method was used to estimate the cumulative probabilities of survival and remaining free of acquired immunodeficiency syndrome. Cox's proportional-hazards analyses were used to identify prognostic factors for survival and progression to acquired immunodeficiency syndrome. Results: The majority of human immunodeficiency virus-infected pregnant women were alive 3 years later. Lymphadenopathy syndrome or herpes genitalis was significantly associated with a subsequent diagnosis of acquired immunodeficiency syndrome. Of the 103 original patients, six had acquired immunodeficiency syndrome at the index delivery and acquired immunodeficiency syndrome developed in 24. Approximately 94% of evaluable patients with development of acquired immunodeficiency syndrome had CD4-lymphocyte counts <200/mm3. The most common opportunistic infection was Pneumocystis carinii pneumonia. Acquired immunodeficiency syndrome and postpartum zidovudine therapy were independent prognostic factors affecting survival. Conclusion: Survival was affected by Centers for Disease Control group status of human immunodeficiency virus infection at the index delivery.

KW - acquired immunodeficiency syndrome (AIDS) in pregnancy, survival of human immunodeficiency virus (HIV)-infected women

KW - Cox's model

KW - time-dependent covariates

UR - http://www.scopus.com/inward/record.url?scp=0026637537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026637537&partnerID=8YFLogxK

M3 - Article

C2 - 1359787

AN - SCOPUS:0026637537

VL - 167

SP - 152

EP - 157

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 1

ER -